Who
George Kemble
Director
Company insider
Files Form 4 as: Executive Chairman, Sagimet Biosciences.
In numbers
- Trades disclosed
- 47
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $8.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Jul 2023
- Last trade
- 14 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $2.1M326,618 at $6.36 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $155K24,369 at $6.36 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $3.6M350,987 at $10.23 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —326,618 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —24,369 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —326,618 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —24,369 at $0.00 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $2.1M326,618 at $6.36 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $155K24,369 at $6.36 | filing |
| 14 Aug 2026filed 17 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $3.6M350,987 at $10.23 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $62K9,751 at $6.36 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $66K10,455 at $6.36 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $201K20,206 at $9.95 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,751 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,455 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,751 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,455 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $62K9,751 at $6.36 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Code M | $66K10,455 at $6.36 | filing |
| 11 Aug 2026filed 12 Aug 2026 | SGMT Sagimet BiosciencesBiotechnology | SEC FORM 4 Sold | $201K20,206 at $9.95 | filing |
News
No headline names them, or the companies they trade most, lately.